why is tirzepatide being discontinued Real-World Use of GLP-1s Yields Less Weight Loss Than Clinical Trials The FDA says the Zepbound

Tirzepatide in Cleveland, OH, is an excellent option for individuals struggling with obesity or those who have difficulty or trouble losing weight through diet and exercise alone

At the same time insulin releasing function of GLP-1 has to be maintained

96374: Intravenous push, single or initial substance/drug 96375: Each additional sequential IV push of a new substance/drug 96376: Each additional IV push of the same drug, given at intervals of 30 minutes or more 96360 and 96361: These are for hydration therapy: 96360 Initial 31 minutes to 1 hour 96361 Each additional hour 90471: Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections)

Anything beyond that starts the degradation clock

However, much of the early change may include water weight and reduced inflammation in addition to body fat